Australia markets closed

Encompass Health Corporation (EHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
91.37-0.29 (-0.32%)
At close: 04:00PM EDT
91.37 0.00 (0.00%)
After hours: 06:13PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
399,500
352,000
271,000
412,200
284,200
-
Depreciation & amortisation
280,600
273,900
243,600
219,600
203,000
-
Deferred income taxes
7,800
3,900
27,900
17,400
34,500
-
Stock-based compensation
50,000
50,600
29,200
29,100
25,600
-
Change in working capital
-4,500
50,300
-30,400
-109,900
108,000
-
Accounts receivable
-33,000
-22,400
-16,900
-39,500
-5,100
-
Accounts payable
9,600
11,800
2,300
15,600
14,100
-
Other working capital
214,700
267,700
121,700
170,100
300,100
-
Other non-cash items
25,800
14,700
30,000
5,200
14,000
-
Net cash provided by operating activities
872,400
850,800
705,800
715,800
704,700
-
Cash flows from investing activities
Investments in property, plant and equipment
-657,700
-583,100
-584,100
-545,700
-404,600
-
Acquisitions, net
-
-
0
-118,600
0
-231,500
Purchases of investments
-
-
-
-
-
-32,900
Sales/maturities of investments
-
-
-
-
-
17,600
Other investing activities
-700
-19,700
-39,400
-1,400
100
-
Net cash used for investing activities
-658,400
-602,800
-627,000
-666,300
-407,500
-
Cash flows from financing activities
Debt repayment
-96,200
-163,300
-750,000
-359,100
-1,106,600
-
Common stock repurchased
-
-
0
0
-6,100
-45,900
Dividends paid
-60,700
-60,400
-99,000
-112,200
-111,800
-
Other financing activities
-62,200
-53,500
-63,600
-58,600
-232,300
-
Net cash used provided by (used for) financing activities
-185,900
-197,200
-660,800
-229,900
-134,300
-
Net change in cash
28,100
50,800
-66,900
-190,600
151,300
-
Cash at beginning of period
154,000
53,400
120,300
310,900
159,600
-
Cash at end of period
182,100
104,200
53,400
120,300
310,900
-
Free cash flow
Operating cash flow
872,400
850,800
705,800
715,800
704,700
-
Capital expenditure
-657,700
-583,100
-584,100
-545,700
-404,600
-
Free cash flow
214,700
267,700
121,700
170,100
300,100
-